BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
8/26/2014 4:36:00 PM | Browse: 1201 | Download: 756
Publication Name World Journal of Gastroenterology
Manuscript ID 6540
Country United States
Received
2013-10-23 13:46
Peer-Review Started
2013-10-24 10:18
To Make the First Decision
2013-12-26 11:21
Return for Revision
2013-12-26 19:23
Revised
2014-01-10 20:56
Second Decision
2014-03-05 15:32
Accepted by Journal Editor-in-Chief
Accepted by Company Editor-in-Chief
2014-03-05 15:39
Articles in Press
Publication Fee Transferred
Edit the Manuscript by Language Editor
Typeset the Manuscript
2014-05-21 16:24
Publish the Manuscript Online
2014-06-06 16:55
ISSN 1007-9327 (print) and 2219-2840 (online)
Open Access
Copyright
Article Reprints For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website http://www.wjgnet.com
Category Gastroenterology & Hepatology
Manuscript Type Case Report
Article Title Rapid improvement in post-infectious gastroparesis symptoms with mirtazapine
Manuscript Source Invited Manuscript
All Author List Shinjini Kundu, Shari Rogal, Abdulkader Alam and David J Levinthal
Funding Agency and Grant Number
Funding Agency Grant Number
University of Pittsburgh Medical Center, Pittsburgh PA, United States
Corresponding Author David J Levinthal, MD, PhD, Assistant Professor of Medicine, Division of Gastroenterology, Hepatology, and Nutrition, Department of Medicine, University of Pittsburgh Medical Center, M2 C-Wing PUH, 200 Lothrop Street, Pittsburgh, PA 15213, United States. levinthald@upmc.edu
Key Words Nausea; Vomiting; Gastroparesis; Symptoms; Mirtazapine; Anti-emetics
Core Tip The management of symptoms associated with severe gastroparesis remains challenging because current therapeutic options are fairly limited. This case report documents the rapid improvement of nausea and vomiting in a patient with severe post-infectious gastroparesis with mirtazapine. Because mirtazapine acts primarily as a serotonin 1a receptor agonist, this receptor system may be an important adjunctive target for nausea and vomiting refractory to standard therapies. Thus, mirtazapine should be considered as a treatment option for gastroparesis.
Publish Date 2014-06-06 16:55
Citation Kundu S, Rogal S, Alam A, Levinthal DJ. Rapid improvement in post-infectious gastroparesis symptoms with mirtazapine. World J Gastroenterol 2014; 20(21): 6671-6674
URL http://www.wjgnet.com/1007-9327/full/v20/i21/6671.htm
DOI http://dx.doi.org/10.3748/wjg.v20.i21.6671
Full Article (PDF) WJG-20-6671.pdf
Full Article (Word) WJG-20-6671.doc
Manuscript File 6540-Review.docx
Answering Reviewers 6540-Answering reviewers.pdf
Copyright License Agreement 6540-Copyright assignment.pdf
Peer-review Report 6540-Peer review(s).pdf
Scientific Editor Work List 6540-Scientific editor work list.doc